v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (39,662) $ (23,988)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Net accretion of discounts on available-for-sale securities (1,765) 0
Depreciation and amortization expense 1,465 928
Accrued interest on held-to-maturity investments 0 (360)
Share-based compensation 4,501 1,375
Other noncash income, net 222 136
Changes in operating assets and liabilities:    
Accounts receivable, net (109) 979
Interest receivable (286) 0
Inventory 0 11
Prepaid expenses and other current assets 259 (93)
Accounts payable and accrued expenses (4,548) (763)
Deferred Income [1] (1,400) 28,000
Accrued personnel expenses (441) (1,279)
Other noncurrent liabilities 229 0
Net cash (used in) provided by operating activities (41,535) 4,946
CASH FLOWS FROM INVESTING ACTIVITIES:    
Additions to property and equipment (5,682) (10,087)
Additions to other assets (45) 0
Purchases of held-to-maturity securities 0 (78,730)
Proceeds from held-to-maturity securities 0 38,225
Purchases of available-for-sale securities (67,094) 0
Maturities of available-for-sale securities 71,520 0
Net cash used in investing activities (1,301) (50,592)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Repayment of note payable (26) (20)
Proceeds from sales of common stock, pursuant to exercise of warrants, net 0 123
Proceeds from sales of common stock, pursuant to exercise of options 145 254
Proceeds from the issuance of common stock and Pre-funded Warrants, net [1] 0 288,055
Proceeds from the sale of common stock pursuant to at-the-market offering, net [1] 9,986 0
Net cash provided by financing activities 10,105 288,412
Net (decrease) increase in cash, cash equivalents and restricted cash (32,731) 242,766
Cash, cash equivalents and restricted cash beginning of period 61,580 9,420
CASH, CASH EQUIVALENTS AND RESTRICTED CASH END OF PERIOD 28,849 252,186
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:    
Cash and cash equivalents 28,849 252,004
Restricted cash 0 182
Total cash, cash equivalents and restricted cash shown on the condensed consolidated statements of cash flows 28,849 252,186
Supplemental schedule of noncash investing and financing activities:    
Recognition of operating lease liability and right-of-use asset 0 1,497
Property and equipment in accounts payable and accrued expenses $ 1,058 $ 0
[1] See Note 3, Investments and Agreements, for additional information.